SAB Biotherapeutics, Inc. - SABS
-
Commons
$0.83
-3.21%SABS Vol: 271.9K
-
Warrants
$0.11
-23.02%SABSW Vol: 32.3K
SPAC Stats
Market Cap: 43.8M
Average Volume: 60.8K
52W Range: $0.37 - $1.63
Weekly %: -3.87%
Monthly %: +1.92%
Inst Owners: 45
Info
🎯Price Targets
Rating
Analyst Firm
Price Target
04/01/22
Buy - $10.0
05/13/22
nan - $7.0
🕵Stocktwit Mentions
FinnessaurusFlex posted at 2023-06-21T13:21:02Z
$SABS $ASTS my fav stocks getting good news this morning 😁😎
EarningsInsider posted at 2023-06-21T13:05:38Z
SAB Biotherapeutics, Inc. Files SEC Form 8-K $SABS https://www.marketbeat.com/stocks/NASDAQ/SABS/sec-filings/
Last10K posted at 2023-06-21T12:56:46Z
$SABS just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/sabs/0001437749-23-017924.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=sabs
Quantisnow posted at 2023-06-21T12:51:38Z
$SABS 📜 SAB Biotherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://quantisnow.com/i/4665205?utm_source=stocktwits 45 seconds delayed.
stockilluminati posted at 2023-06-21T12:51:09Z
$SABS https://www.stockilluminati.com/sabs/filings.php - SAB Biotherapeutics, Inc. - Common Stock files form 8-K today, check out the details.
STCKPRO posted at 2023-06-21T12:45:51Z
$SABS NEW ARTICLE : SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023 https://www.stck.pro/news/SABS/53721839/
fla posted at 2023-06-21T12:31:46Z
$SABS [15s. delayed]: Issued Press Release on June 21, 08:30:00: SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study f https://s.flashalert.me/nAuSn
Quantisnow posted at 2023-06-21T12:30:56Z
$SABS 📰 SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023 https://quantisnow.com/i/4664987?utm_source=stocktwits 45 seconds delayed.
Stock_Titan posted at 2023-06-21T12:30:10Z
$SABS $SABSW SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023 https://www.stocktitan.net/news/SABS/sab-biotherapeutics-presents-positive-ind-enabling-glp-toxicology-tx9gnt8qly1n.html
moneystreet posted at 2023-06-21T12:10:12Z
SAB Biotherapeutics Says Diabetes Immunotherapy Shows Therapeutic Effect In Toxicology Study $SABS
DDiamond_Handz posted at 2023-06-20T14:14:18Z
$SABS that's one way to start the week
tickeron posted at 2023-06-19T14:53:11Z
Don't miss this opportunity! $SABS in -3.85% Downtrend, sliding for three consecutive days on June 13, 2023. View odds for this and other indicators: https://srnk.us/go/4740807
ChartMill posted at 2023-06-18T19:56:00Z
$SABS was analyzed by 9 analysts. The buy consensus is at 84%. So analysts seem to be very confident about $SABS. https://www.chartmill.com/stock/quote/SABS/analyst-ratings?utm_source=stocktwits&utm_medium=ANALYST&utm_content=SABS&utm_campaign=social_tracking
JTebow_CWS posted at 2023-06-17T00:18:26Z
$ASTS $SABS @WOLFSTREET A new idiot to block.
WOLFSTREET posted at 2023-06-16T23:29:08Z
$ASTS $SABS I get it now, you are possibly holding bags here and think I am the cause. Well, I am not, it is you and traders against the market. I just know better about what and when to trade an asset.
WOLFSTREET posted at 2023-06-15T18:45:26Z
@FinnessaurusFlex The price would beg to differ on all three $SABS $ASTS $ORGN , at least up until now. which to me remains a lot of hope and dreams on each. for your sake I certainly "hope" they all pull through. Just curious about the thesis. The story is one thing the price action is another...
FinnessaurusFlex posted at 2023-06-15T18:38:32Z
$SABS
WOLFSTREET posted at 2023-06-15T18:22:00Z
$ORGN $ASTS $SABS so if you have observed many/most spacs to be scams, which I totally agree about The Great SPAC Scam!, what would differentiate these two?
FinnessaurusFlex posted at 2023-06-15T17:50:40Z
$SABS having thousands of shares with a sub $1 average could be my greatest W in the next few years. Trust the cows! 🐄🧬
FinnessaurusFlex posted at 2023-06-15T17:48:58Z
$SABS a lot of my investment ideas have not panned out as expected. Many Spacs turned out to be scams one way or another. This company, $ASTS and $ORGN are a few of the previous spacs that are severely undervalued and will have their day eventually 🚀 I feel comfortable and excited holding these stocks.
stockboyaisle1 posted at 2023-06-15T17:01:54Z
$SABS Watched R&D presentation. Outstanding IMO. The innovation, technology, management and team all add up to a positive future for SAB, science, medicine and mankind. Revolutionary changes of this kind take time. Rewards for patience will come. Thanks SAB for all of your dedication to what you are doing.
JTebow_CWS posted at 2023-06-15T15:40:36Z
$SABS That was a powerhouse line up yesterday.
DreySamuelson posted at 2023-06-14T18:46:27Z
$SABS I just attended the SAB annual meeting in Sioux Falls... really stunningly wonderful presentation--there is every reason to be very optimistic about SAB's future! I have what for me is a fortune invested in SABS, but might even buy some more...
EarningsInsider posted at 2023-06-14T12:59:56Z
SAB Biotherapeutics, Inc. Files SEC Form 8-K $SABS https://www.marketbeat.com/stocks/NASDAQ/SABS/sec-filings/
Last10K posted at 2023-06-14T12:56:05Z
$SABS just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/sabs/0001437749-23-017353.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=sabs
Quantisnow posted at 2023-06-14T12:55:43Z
$SABS 📜 SAB Biotherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://quantisnow.com/i/4639596?utm_source=stocktwits 45 seconds delayed.
fla posted at 2023-06-14T12:55:30Z
$SABS [15s. delayed] filed form 8-K on June 14, 08:53:08 https://s.flashalert.me/sFiwJv
JTebow_CWS posted at 2023-06-13T03:27:08Z
$SABS Twitter
DDiamond_Handz posted at 2023-06-12T11:59:21Z
$SABS fda clearance by July?
stockboyaisle1 posted at 2023-06-09T15:53:28Z
$SABS Dr. Sullivan’s Bio Tech Convention presentation: https://ir.sab.bio/investor-relations/
Holder Stats
| 1 | 0 |
|---|---|
| % of Shares Held by All Insider | 29.55% |
| % of Shares Held by Institutions | 8.14% |
| % of Float Held by Institutions | 11.55% |
| Number of Institutions Holding Shares | 45 |
Mutual Fund Holders
| Holder | Shares | Date Reported | Value | % Out |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 340547 | 2022-12-30 | 200888 | 0.6799999999999999 |
| Vanguard Total Stock Market Index Fund | 338972 | 2022-12-30 | 199959 | 0.67 |
| Fidelity Extended Market Index Fund | 139777 | 2023-02-27 | 90855 | 0.27999999999999997 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 84000 | 2022-12-30 | 49551 | 0.16999999999999998 |
| Fidelity Total Market Index Fund | 85867 | 2023-02-27 | 55813 | 0.16999999999999998 |
| iShares Micro Cap ETF | 53316 | 2023-02-27 | 34655 | 0.11 |
| Fidelity Series Total Market Index Fund | 35086 | 2023-02-27 | 22805 | 0.07 |
| Schwab Capital Trust-Total Stock Market Index Fund | 16238 | 2023-01-30 | 11032 | 0.03 |
| Fidelity NASDAQ Composite Index Fund | 14671 | 2023-02-27 | 9536 | 0.03 |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 10730 | 2022-12-30 | 6329 | 0.02 |
Institutional Holders
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company |
|---|---|---|---|---|---|---|
| 2023-05-16 | First Manhattan CO. LLC. | 277,777 | $120,000 | 0.0% | 0 | 0.551% |
| 2023-02-16 | Shaolin Capital Management LLC | 236,621 | $140,000 | 0.0% | -14.0% | 0.469% |
| 2023-02-15 | Meteora Capital LLC | 134,524 | $79,000 | 0.0% | -46.1% | 0.267% |
| 2023-02-13 | Geode Capital Management LLC | 300,529 | $180,000 | 0.0% | -5.1% | 0.596% |
| 2023-02-09 | HighTower Advisors LLC | 75,970 | $44,000 | 0.0% | 0 | 0.151% |
| 2023-02-02 | Silver Oak Securities Incorporated | 51,941 | $31,000 | 0.0% | 0 | 0.121% |
| 2022-11-15 | Vanguard Group Inc. | 701,003 | $490,000 | 0.0% | -2.9% | 1.629% |
| 2022-11-15 | Citadel Advisors LLC | 40,162 | $28,000 | 0.0% | 0 | 0.093% |
| 2022-11-07 | Institutional & Family Asset Management LLC | 149,774 | $110,000 | 0.0% | +91.7% | 0.348% |
| 2022-10-20 | First PREMIER Bank | 807,535 | $570,000 | 0.2% | +23.8% | 1.877% |
| 2022-08-15 | State Street Corp | 81,241 | $120,000 | 0.0% | +91.9% | 0.189% |
| 2022-08-15 | Millennium Management LLC | 64,220 | $93,000 | 0.0% | 0 | 0.149% |
| 2022-08-15 | LGL Partners LLC | 23,000 | $33,000 | 0.0% | 0 | 0.054% |
| 2022-08-03 | AE Wealth Management LLC | 18,700 | $27,000 | 0.0% | 0 | 0.044% |
| 2022-07-26 | First PREMIER Bank | 652,440 | $950,000 | 0.3% | 0 | 1.519% |
| 2022-05-16 | State Street Corp | 42,341 | $160,000 | 0.0% | +244.2% | 0.099% |
| 2022-05-13 | Vanguard Group Inc. | 721,151 | $2,710,000 | 0.0% | +5.6% | 1.679% |
| 2022-05-09 | Qube Research & Technologies Ltd | 24,179 | $91,000 | 0.0% | +43.8% | 0.056% |
| 2022-02-14 | Radcliffe Capital Management L.P. | 546,658 | $5,520,000 | 0.1% | 0 | 1.257% |
| 2022-02-14 | ETF Managers Group LLC | 13,202 | $110,000 | 0.0% | 0 | 0.030% |
| 2022-02-14 | Institutional & Family Asset Management LLC | 78,115 | $610,000 | 0.1% | 0 | 0.180% |
| 2022-02-10 | Qube Research & Technologies Ltd | 16,817 | $130,000 | 0.0% | 0 | 0.039% |
| 2022-02-09 | Wolverine Asset Management LLC | 6,602 | $51,000 | 0.0% | 0 | 0.015% |
| 2022-02-09 | Alps Advisors Inc. | 50,306 | $390,000 | 0.0% | 0 | 0.116% |
| 2022-02-03 | Spectrum Management Group LLC | 5,030 | $39,000 | 0.0% | 0 | 0.012% |
| 2022-02-01 | Qube Research & Technologies Ltd | 16,817 | $130,000 | 0.0% | 0 | 0.039% |
| 2022-01-19 | First PREMIER Bank | 832,555 | $6,500,000 | 1.7% | 0 | 1.915% |
| 2022-01-18 | Nadler Financial Group Inc. | 11,000 | $86,000 | 0.0% | 0 | 0.025% |
| 2021-11-17 | Tudor Investment Corp Et Al | 60,000 | $610,000 | 0.0% | 0 | 0.406% |